Search for: "AstraZeneca AB"
Results 61 - 80
of 92
Sorted by Relevance
|
Sort by Date
23 Aug 2019, 6:23 am
For an example of a bad interpretation of a complex contract that might have come out the right way with a little help of signals in the contract, take a look at Astex Therapeutics Limited and AstraZeneca AB, [2018] EWCA Civ. 2444, Case No. [read post]
18 Mar 2016, 2:04 pm
Del. 2015), and AstraZeneca AB v. [read post]
12 Oct 2010, 8:56 pm
Apotex asks Supreme Court to review generic Cozaar/Hyzaar 180-day exclusivity decision (FDA Law Blog) Faslodex (Fulvestrant) – US: AstraZeneca seeks review of BPAI decision concerning patent covering ‘Use of Fulvestrant in treatment of resistant breast cancer’ (Patent Docs) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement complaint against Dr Reddy’s following Para IV certification (Patent Docs) Lipitor (Atorvastatin) – US: Generic LIPITOR… [read post]
6 Oct 2009, 4:00 am
AstraZeneca was formed through a 1999 merger between Britain's Zeneca Group PLC and Sweden's Astra AB, the parent of Astra USA.Corporate boards face mounting pressure to crack down on executives who breach their fiduciary duty, said Thomas C. [read post]
2 Feb 2016, 12:46 pm
”); Astrazeneca AB v. [read post]
4 Sep 2014, 1:00 am
So changing the CGK analysis inevitably changes the test for inventive step.All of this helps explain why the IPKat is so exercised by yesterday’s decision in Teva UK Limited & another v AstraZeneca AB [2014] EWHC 2873 (Pat), decided by Mr Justice Sales in the Patents Court. [read post]
14 Oct 2007, 6:39 pm
Pharmaceutical company AstraZeneca PLC, whose predecessor company, Astra AB, started off in China in 2000 with a manufacturing plant and a sales operation, has expanded its clinical-trials program here, added research staff and opened a purchasing operation. [read post]
1 Jun 2015, 3:33 pm
******************PREVIOUSLY, ON NEVER TOO LATE Never too late 47 [week ending on Sunday 24 May] - Nicolas Sarkozy and the IP | Another reference on TM licences to the CJEU | UPC test-drive | Swatch v Swatchball | New Lisbon Treaty on appellations of origin and geographical indications | UP reneal fees | Synthon v Teva | GC on Yoshida | UPC Court fees event | EPO staff under fire | The trade-secret option | Damages |AstraZeneca AB & Another v… [read post]
15 Jun 2015, 7:13 am
******************PREVIOUSLY, ON NEVER TOO LATE Never too late 49 [week ending on Sunday 31 May] - Another copyright-exhaustion-and-software reference to the CJEU | ORO trade marks and GC | Patent Reform in EU | Copyright in the Bahamas | More and more references to the CJEU: communication to the public and linking | Trade secrets and the FoMo phenomenon | Independence of EPO’s BoA.Never too late 48 [week ending on Sunday 31 May] - The… [read post]
8 Jun 2015, 4:20 am
******************PREVIOUSLY, ON NEVER TOO LATE Never too late 48 [week ending on Sunday 31 May] - The meaning of EPO appeal system | 3D Printing and the law | Epo and external investigation firms | Umbrella designs | US Supreme Court in Commil USA, LLC v Cisco Systems | European Inventor Award | FIFA and brand integrity | Warner-Lambert v Actavis | Wine in Black GmbH v OHIM | IP and busking | Swiss-style claims.Never too late… [read post]
10 Jan 2018, 6:36 pm
” AstraZeneca AB v.Apotex Corp., 782 F.3d 1324, 1334 (Fed. [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
10 Mar 2010, 5:22 am
(Patentcircle) (GenericsWeb) Glazide (Gliclazidium) – Poland: Supreme Administrative Court: Glazide is distinctive (Class 46) Januvia (Sitagliptin) - EU: Partial translation of German Sitagliptin referral to the ECJ (The SPC Blog) Nexium IV (Esomeprazole) – US: Infringement of patent following a Paragraph IV certification: AstraZeneca AB et al. v. [read post]
10 Aug 2011, 4:30 am
(FDA Law Blog) Lipitor (Atorvastatin) – The fight for Atorvastatin: further news (The SPC blog) Nexium (Esomeprazole magnesium) – US: Patent infringement complaint filed following a Paragraph IV certification: Astrazeneca AB et al. v. [read post]
10 Mar 2010, 5:22 am
(Patentcircle) (GenericsWeb) Glazide (Gliclazidium) – Poland: Supreme Administrative Court: Glazide is distinctive (Class 46) Januvia (Sitagliptin) - EU: Partial translation of German Sitagliptin referral to the ECJ (The SPC Blog) Nexium IV (Esomeprazole) – US: Infringement of patent following a Paragraph IV certification: AstraZeneca AB et al. v. [read post]
3 Oct 2009, 9:05 pm
" Astrazeneca AB v. [read post]
25 Mar 2016, 3:16 pm
AstraZeneca Pharm. [read post]
31 Jul 2013, 4:58 am
Astrazeneca Pharms. [read post]
25 May 2015, 4:15 am
, Paul Inman and Ailsa Carter, have summarised last week's decision from the Court of Appeal in AstraZeneca AB & Another v KRKA dd Novo Mesto & Another [2015] EWCA Civ 484.* F1 ends up in hot water - no similarity to F1H2OIn Case T-55/13 the General Court of the European Union deals with Formula One Licensing BV's opposition against Idea Marketing SA’s Community trade mark application for 'F1H2O'. [read post]
8 Sep 2014, 4:55 am
.* The skilled person - more knowledgeable than ever beforeDavid covers the exciting pharma-patent ruling in Teva UK Limited & another v AstraZeneca AB [2014] EWHC 2873 (Pat) by Mr Justice Sales in the Patents Court for England and Wales, which focuses on the concept of Common General Knowledge (CGK). [read post]
